References
Cappell MS, Seibold JR: Mesenteric thrombosis associated with anticardiolipin antibodies in a patient with systemic lupus erythematosus. Am J Gastroenterol 87:520–522, 1992
Cappell MS, Simon T, Tiku M: Splenic infarction associated with anticardiolipin antibodies in a patient with the acquired immunodeficiency syndrome. Dig Dis Sci 38:1152–1155, 1993
Love PE, Santoro SA. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 112:682–698, 1990
Asherson RA, Mackworth-Young CG, Harris EN, Gharavi AE, Hughes GR: Multiple venous and arterial thromboses associated with the lupus anticoagulant and antibodies to cardiolipin in the absence of SLE. Rheumatol Int 5:91–93, 1985
Asherson RA, Morgan SH, Harris EN, Gharavi AE, Krausz T, Hughes GR: Arterial occlusion causing large bowel infarction: A reflection of clotting diathesis in SLE. Clin Rheumatol 5:102–106, 1986
Hamilton ME: Superior mesenteric artery thrombosis associated with antiphospholipid syndrome. West J Med 155:174–176, 1991
Sanchez-Guerrero J, Reyes E, Alarcon-Segovia D: Primary antiphospholipid syndrome as a cause of intestinal infarction. J Rheumatol 19:623–625, 1992
Reinus JF, Brandt LJ, Boley SJ: Ischemic diseases of the bowel. Gastrointest Clin North Am 19:319–343, 1990
Williams LF Jr: Mesenteric ischemia. Surg Clin North Am 68:331–353, 1988
Clark WF, Tevaarwerk GJM, Reid BD. Human plateletimmune complex interaction in plasma. J Lab Clin Med 100:917–931, 1982
Mueh JR, Herbst KD, Rapaport SI: Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 92:156–159, 1980
Angles-Cano E, Sultan Y, Clauvel JP: Predisposing factors to thrombosis in systemic lupus erythematosus: Possible relation to endothelial cell damage. J Lab Clin Med 94:312–323, 1979
Danao T, Camara EG: The anticardiolipin syndrome. Am Fam Physician 39:107–110, 1989
Pengo V, Thiagarajan P, Shapiro SS, Heine MJ: Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood 70:69–76, 1987
Sanfelippo MJ, Drayna CJ: Prekallikrein inhibition associated with the lupus anticoagulant: Mechanism of thrombosis. Am J Clin Pathol 77:275–279, 1982
Asherson RA, Thompson RPH, MacLachlan N, Baguley E, Hicks P, Hughes GRV: Budd-Chiari syndrome, visceral arterial occlusions, recurrent fetal loss and the lupus anticoagulant in systemic lupus erythematosus. J Rheumatol 16:219–224, 1989
Averbuch M, Levo Y: Budd-Chiari syndrome as the major thrombotic complication of systemic lupus erythematosus with the lupus anticoagulant. Ann Rheum Dis 45:435–437, 1986
Farrant JM, Judge M, Thompson RPH: Thrombotic cutaneous nodules and hepatic vein thrombosis in the anticardiolipin syndrome. Clin Exp Dermatol 14:306–308, 1989
Mackworth-Young CG, Melia WM, Harris EN, Gharavi AE, Sirathondan Y, Derne G, Sherlock S, Hughes GRV: The Budd-Chiari syndrome: Possible pathogenetic role of antiphospholipid antibodies. J Hepatol 3:83–86, 1986
Nakamura H, Uehara H, Kambe H, Kimura Y, Ito M, Hayashi E, Yamamoto H, Kishimoto S. Occlusion of small hepatic veins associated with systemic lupus erythematosus with the lupus anticoagulant and anti-cardiolipin antibody. Hepato-Gastroenterol 36:393–397, 1989
van Steenbergen W, Beyls J, Vermylen J, Fenery J, Marchol G, Desmet V, de Groote J: Lupus anticoagulant and thrombosis of the hepatic veins (Budd-Chiari syndrome): Report of three patients and review of the literature. J Hepatol 3:87–94, 1986
Pomeroy C, Knodell RG, Swaim WR, Arneson P, Mahowald ML: Budd-Chiari syndrome in a patient with the lupus anticoagulant. Gastroenterology 86:158–161, 1984
Roudota-Thoraval F, Gouault-Heilmann M, Zafrani ES, Baye J, Dhumeaux D: Budd-Chiari syndrome and the lupus anticoagulant. Gastroenterology 88:605, 1985 (letter)
Bendon RW, Wilson J, Getahun B, van der Bel-Kahn J: A maternal death due to thrombotic disease associated with anticardiolipin antibody. Arch Pathol Lab Med 111:370–372, 1987
DeClerck LS, Michielsen PP, Ramael MR, Janssens E, van Maercke YM, van Marck EA, Stevens WJ: Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies. J Rheumatol 18:1919–1921, 1991
Ordi J, Vargas V, Vilardell M, Basquinero J, Guardia J: Lupus anticoagulant and portal hypertension. Am J Med 84:566–567, 1988
Griesman SG, Thayaparan RS, Godwin TA, Lockshin MD: Occlusive vasculopathy in systemic lupus erythematosus: Association with anticardiolipin antibody. Arch Intern Med 151:389–392, 1991
Mor F, Beigel Y, Jubal A, Goren M, Wysenbeck AJ: Hepatic infarction in a patient with the lupus anticoagulant. Arthritis Rheum 32:491–495, 1989
Wang CR, Hsieh HC, Lee GL, Chuang CY, Chen CY: Pancreatitis related to antiphospholipid antibody syndrome in a patient with systemic lupus erythematosus. J Rheumatol 19:1123–1125, 1992
Gastineau DA, Kazmier FJ, Nichols WL, Bowie EJW: Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 cases. Am J Hematol 19:265–275, 1985
Shapiro S, Thiagarajan P: Lupus anticoagulant. Prog Haemost Thromb 6:263–285, 1982
Perez RE, McClendon JR, Lie JT: Primary antiphospholipid syndrome with multiorgan arterial and venous thromboses. J Rheumatol 19:1289–1292, 1992
Freudenberger RS, Cappell MS, Hutt DA: Intestinal infarction following intravenous cocaine administration. Ann Intern Med 113:715–716, 1990
Cappell MS, Simon T. Colonic toxicity due to administered medi ations or compounds. Am J Gastroenterol 88:1684–1699, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cappell, M.S., Mikhail, N. & Gujral, N. Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies. Digest Dis Sci 39, 1359–1364 (1994). https://doi.org/10.1007/BF02093805
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02093805